By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:


SEARCH JOBS
FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.


Key Statistics


Email:
Ownership: Private

Web Site: FDA
Employees:
Symbol: 
 



Industry
Government






Company News
Roche (RHHBY) Release: Breakthrough Development For Americans With Suspected Heart Attack - Next Generation Troponin T Test From Company Cleared By FDA 1/19/2017 10:41:07 AM
SoCal's Modulated Imaging Wins FDA Nod for Ox-Imager CS System 1/19/2017 9:01:30 AM
Symbiomix Release: Pharma Submits New Drug Application To US FDA For Solosec For The Treatment Of BV 1/19/2017 8:02:08 AM
Synthetic Biologics (SYN) Release: Company Confirms Key Features Of Pivotal Phase 2b/3 Trial Of SYN-010 Pursuant To Consultations With FDA 1/19/2017 7:26:16 AM
Ezra Release: Company Announces FDA Acceptance Of Filing Of New Drug Application For EZR-104 For The Treatment Of Hypertension And Heart Failure 1/19/2017 7:25:10 AM
AbbVie (ABBV) Release: U.S. FDA Approves Imbruvica (Ibrutinib) As First Treatment Specifically Indicated For Relapsed/Refractory Marginal Zone Lymphoma (Mzl) - A Rare Type Of Non-Hodgkin's Lymphoma 1/19/2017 7:23:07 AM
Janssen Biotech (JNJ) Release: IMBRUVICA (Ibrutinib) Approved By FDA For Marginal Zone Lymphoma (MZL) Patients Who Require Systemic Therapy And Have Received At Least One Prior Anti-CD20-Based Therapy 1/19/2017 7:21:54 AM
Shire (SHPG) Release: FDA Acknowledges Receipt Of The Company's NDA For ADHD Drug 1/19/2017 7:09:39 AM
Adamis (ADMP) Release: Company Announces NDA Resubmission Of Its Epinephrine Pre-Filled Syringe Application To The FDA 1/19/2017 7:07:15 AM
Allergan (AGN) Release: Pharma Announces FDA Approval Of Rhofade (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults 1/19/2017 6:58:02 AM
12345678910...
//-->